Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR‐136‐5p

Author:

Xiong Youyi1,Li Lin1,Wang Nan1,Wang Fang1,Chen Zhuo1,Han Luhong1,Jiang Shan1,Gu Yuanting1ORCID

Affiliation:

1. Department of Breast Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou City China

Abstract

AbstractBackgroundGrowing evidence has revealed the critical regulatory role for circular RNAs (circRNAs) in cancer. This study aimed to explore the function of circ_0001387 in breast cancer (BC).MethodsCirc_0001387, miR‐136‐5p, and spindle and kinetochore‐associated protein 2 (SKA2) levels were analyzed by quantitative real‐time polymerase chain reaction. Clone formation and 5‐ethynyl‐2′‐deoxyuridine assays were used to analyze cell proliferation. Cell apoptosis and cell migration and invasion abilities were analyzed using flow cytometry or transwell assay. Mechanism assay was used to confirm the association between miR‐136‐5p and circ_0001387 or SKA2. The effect of circ_0001387 on tumor growth in vivo was analyzed by the xenograft mice model.ResultsCirc_0001387 and SKA2 were expressed at high levels, whereas miR‐136‐5p was lowly expressed in BC tissues and cells. Meanwhile, the downregulation of circ_0001387 restrained BC cell progression in vitro and in vivo. Circ_0001387 competitively bound to miR‐136‐5p to regulate BC cell malignant behaviors. SKA2 was targeted by miR‐136‐5p, and SKA2 reinstated the suppressive effect of miR‐136‐5p upregulation in BC cells.ConclusionOur study indicated that circ_0001387 contributed to BC cell progression through miR‐136‐5p/SKA2 axis.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3